FDA Releases Guidance on Financial Disclosure by Clinical Investigators

Summary

The Food and Drug Administration (FDA) has made available a guidance document clarifying the implementation of a final rule requiring pharmaceutical companies to disclose the financial interests of clinical investigators involved in clinical trials, which took effect on February 2, 1999.